SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)

CAPS Rating: 4 out of 5

A biopharmaceutical company, which is engaged in the development and commercialization of novel therapeutics to treat life-threatening diseases.

Recs

0
Player Avatar pchop123 (78.31) Submitted: 11/12/2012 4:55:16 PM : Outperform Start Price: $4.75 SCLN Score: -3.25

Bet on more upside here

Featured Broker Partners


Advertisement